CW
UTHR icon

CreativeOne Wealth’s United Therapeutics UTHR Stock Holding History

CreativeOne Wealth’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.67M Buy
3,086
+678
+28% +$382K 0.04% 412
2026
Q1 		$1.43M Sell
2,408
-733
-23% -$365K 0.03% 453
2025
Q4 		$1.53M Buy
+3,141
New +$1.46M 0.04% 402
2025
Q2 		– Sell
-764
Closed -$236K – 1189
2025
Q1 		$236K Buy
764
+141
+23% +$48.3K 0.01% 950
2024
Q4 		$220K Buy
623
+23
+4% +$8.45K 0.01% 991
2024
Q3 		$215K Buy
+600
New +$203K 0.01% 882

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

CreativeOne Wealth's UTHR Position: Q2 2026 in Review

CreativeOne Wealth increased its United Therapeutics (UTHR) stake by 28% in Q2 2026, buying an estimated $382K and bringing the position to 3,086 shares worth $1.67M. The position accounts for 0.04% of the portfolio, ranked #412.

CreativeOne Wealth first reported a position in UTHR in Q3 2024 and has held it in 6 quarters since. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • CreativeOne Wealth held 3,086 shares of United Therapeutics worth $1.67M as of Q2 2026.
  • CreativeOne Wealth bought 678 United Therapeutics shares in Q2 2026, an estimated $382K.
  • United Therapeutics made up 0.04% of CreativeOne Wealth's portfolio in Q2 2026, its #412 holding.
  • CreativeOne Wealth first reported a position in United Therapeutics in Q3 2024 and has held it in 6 quarters since.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on CreativeOne Wealth's 13F filing for Q2 2026, filed 13 Aug 2026.